Steven Cohen Abeona Therapeutics Inc. Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$3.71 - $5.14 $1.56 Million - $2.16 Million	-420,200 Reduced 35.58%	760,870 $3.81 Million
Q3 2023 Nov 14, 2023	BUY	$2.98 - $4.43 $147,948 - $219,936	49,647 Added 4.39%	1,181,070 $4.97 Million
Q2 2023 Aug 14, 2023	SELL	$2.76 - $5.27 $53,060 - $101,315	-19,225 Reduced 1.67%	1,131,423 $4.56 Million
Q4 2022 Feb 14, 2023	BUY	$2.4 - $4.39 $2.76 Million - $5.05 Million	1,150,648 New	1,150,648 $3.54 Million

14.4M

715K

58K

Ticker ABEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,950,380
Market Cap $25.1M
Description
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.